Search

everythinglearnresearchcommunity

for

Search:↓

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Finasteride may help treat female hair loss, but has risks.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

5-ARI therapy may help prevent prostate cancer progression.

Urologists should screen for mental health issues before and during finasteride treatment.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Post-finasteride syndrome is rarely linked to sexual and systemic side effects.

Finasteride may cause depression and suicidal thoughts, especially in young men.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Conventional treatments like dutasteride and minoxidil are effective for male hair loss, with some alternative treatments also showing promise.

Medications improve quality of life for men with lower urinary tract symptoms.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Finasteride use is not clearly linked to an increased risk of male breast cancer.